TNYA

Tenaya Therapeutics, Inc. - Common Stock (TNYA)

About Tenaya Therapeutics, Inc. - Common Stock (TNYA)

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.

Details

Daily high

$0.87

Daily low

$0.73

Price at open

52 Week High

$4.06

52 Week Low

$0.36

Market cap

140.9M

Dividend yield

0.00%

Volume

13,584

Avg. volume

2.6M

P/E ratio

-.75

Tenaya Therapeutics, Inc. - Common Stock News